{"id":"W2784719900","doi":"10.1002/hep.29541","title":"Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial","year":2017,"lang":"en","type":"article","venue":"Hepatology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"Gilead Sciences; Bristol-Myers Squibb","keywords":"Medicine; Ribavirin; Internal medicine; Sofosbuvir; Cirrhosis; Gastroenterology; Adverse effect; Discontinuation; Pegylated interferon; Randomized controlled trial; Hepatitis C; Hepatitis C virus; Clinical endpoint; Population; Surgery; Immunology; Virus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007014275,0.0003643239,0.001945087,0.0001281817,0.0005512858,0.0001071361,0.0002667115,0.0003108495,0.000565543],"category_scores_gemma":[0.003606097,0.0002315458,0.0003321593,0.00006910288,0.001142142,0.0001955885,0.000128866,0.000214095,0.00005095265],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000142584,"about_ca_system_score_gemma":0.000634681,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002184538,"about_ca_topic_score_gemma":0.003684306,"domain_scores_codex":[0.9965395,0.0005526156,0.001033719,0.0007994084,0.0003977628,0.0006770426],"domain_scores_gemma":[0.9966602,0.001045355,0.0004764223,0.00102236,0.0002981276,0.000497586],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5320876,0.001610945,0.3460649,0.00003688848,0.0003641231,0.00008966828,0.0003264814,1.876662e-8,0.00002491382,0.00005245122,0.0002706763,0.1190713],"study_design_scores_gemma":[0.9276805,0.01892785,0.01740544,0.00006289867,0.0005972084,0.00001710683,0.00001027642,0.001442846,0.0005066761,0.00003826925,0.03301289,0.0002980196],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9897991,0.0002233099,0.0005670235,0.0006857084,0.0005592351,0.007611019,0.0001651681,0.00006299114,0.0003263732],"genre_scores_gemma":[0.9891319,0.003855292,0.002390635,0.0004036824,0.0003456927,0.003270479,0.0001269946,0.00006087264,0.0004144899],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3955929,"threshold_uncertainty_score":0.9442162,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1280204162060008,"score_gpt":0.465570049319711,"score_spread":0.3375496331137102,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}